Taoling Yuyang Decoction alleviates DSS-induced ulcerative colitis in mice by regulating gut microbiota -metabolite axis and restore intestinal barrier function
Open Access
- 29 April 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 17, 1750380
Abstract
Background: Traditional Chinese medicine (TCM) offers multi-targeted therapy with few side effects for ulcerative colitis (UC). Taoling Yuyang Decoction (TLYY) has shown clinical efficacy, however, its mechanisms of action are unclear. This study employed a multi-omics approach to elucidate TLYY’s therapeutic effects in a murine DSS-induced colitis model. Methods: Using a DSS-induced mouse model of colitis, animals were divided into five groups ( n = 8): blank control (CK), model (DSS), low- and high-dose TLYY (TLYYL, TLYYH), and positive control (5-ASA). Treatment efficacy was assessed by measuring body weight, disease activity index (DAI), and histopathological changes. Oxidative stress markers (MDA, GSH-Px, SOD) in serum and colon tissues were quantified using commercial kits and immunohistochemistry. Cytokine levels (IL-1β, TNF-α, IL-6) and LPS were measured by ELISA. The expression of tight junction proteins (ZO-1, Occludin, Claudin-1) in colon tissue was analyzed via qPCR and immunocytochemistry. Additionally, 16S rDNA sequencing and metabolomics were employed to examine gut microbiota composition, fecal SCFAs, and differential metabolites. Results: Taoling Yuyang Decoction treatment dose-dependently alleviated UC symptoms, including weight loss, colon shortening, and tissue damage. It enhanced antioxidant activities (SOD, GSH-Px) and reduced MDA, suppressed pro-inflammatory cytokines and LPS, and up-regulated tight junction proteins (ZO-1, Occludin, Claudin-1). Gut microbiota analysis showed TLYY-H restored microbial diversity, increased beneficial bacteria (e.g., Lactobacillus , Akkermansia ), and decreased harmful genera (e.g., Helicobacter ). It also elevated SCFA levels and modulated fecal metabolism, up-regulating anti-inflammatory/antioxidant metabolites while down-regulating toxic compounds. Key pathways such as AGE-RAGE signaling and xenobiotic metabolism were restored. Conclusion: Taoling Yuyang Decoction ameliorates DSS-induced colitis via integrated mechanisms involving oxidative stress reduction, anti-inflammation, intestinal barrier repair, and restoration of gut flora homeostasis and metabolic pathways. The superior effect of the high dose highlights its clinical potential for UC treatment.Keywords
This publication has 41 references indexed in Scilit:
- Piezo1 promotes colitis progression by modulating the Nrf2/NF-κB/NLRP3 signaling pathwayBiochemical Pharmacology, 2025
- Lactobacillus plantarum with lignin prevents Helicobacter pylori mediated DSS‐colitis through improved intestinal integrity and reducing colonic inflammation in C57BL/6J miceJournal of the Science of Food and Agriculture, 2025
- Astragalus polysaccharides alleviate DSS-induced ulcerative colitis in mice by restoring SCFA production and regulating Th17/Treg cell homeostasis in a microbiota-dependent mannerCarbohydrate Polymers, 2024
- Apple polyphenols prevent patulin-induced intestinal damage by modulating the gut microbiota and metabolism of the gut-liver axisFood Chemistry, 2024
- Engineered probiotic ameliorates ulcerative colitis by restoring gut microbiota and redox homeostasisCell Host & Microbe, 2024
- Abelmoschus manihot polysaccharide fortifies intestinal mucus barrier to alleviate intestinal inflammation by modulating Akkermansia muciniphila abundanceActa Pharmaceutica Sinica B, 2024
- Gingerenone A Attenuates Ulcerative Colitis via Targeting IL‐17RA to Inhibit Inflammation and Restore Intestinal Barrier FunctionAdvanced Science, 2024
- Targeting Desulfovibrio vulgaris flagellin-induced NAIP/NLRC4 inflammasome activation in macrophages attenuates ulcerative colitisJournal of Advanced Research, 2023
- Dietary fiber and SCFAs in the regulation of mucosal immunityJournal of Allergy and Clinical Immunology, 2022
- The key role of gut–liver axis in pyrrolizidine alkaloid-induced hepatotoxicity and enterotoxicityActa Pharmaceutica Sinica B, 2021